These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 33015105)

  • 1. Comparison of Oncological and Surgical Outcomes Between Formal Pancreatic Resections and Parenchyma-Sparing Resections for Small PanNETs (<2 cm): Pancreas2000 Research and Educational Program (Course 9) Study Protocol.
    Pea A; Tanno L; Nykänen T; Prasad P; Tunçer C; Robinson S; Marchegiani G
    Front Med (Lausanne); 2020; 7():559. PubMed ID: 33015105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conservative management and parenchyma-sparing resections of pancreatic neuroendocrine tumors: Literature review.
    Mauriello C; Napolitano S; Gambardella C; Candela G; De Vita F; Orditura M; Sciascia V; Tartaglia E; Lanza M; Santini L; Conzo G
    Int J Surg; 2015 Sep; 21 Suppl 1():S10-4. PubMed ID: 26118605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of Current ENETS Guidelines for Surgery of Small (≤2 cm) Pancreatic Neuroendocrine Neoplasms in the German Surgical Community: An Analysis of the Prospective DGAV StuDoQ|Pancreas Registry.
    Mintziras I; Keck T; Werner J; Fichtner-Feigl S; Wittel U; Senninger N; Vowinkel T; Köninger J; Anthuber M; Geißler B; Bartsch DK;
    World J Surg; 2019 Jan; 43(1):175-182. PubMed ID: 30097704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre- and intraoperative diagnostic requirements, benefits and risks of minimally invasive and robotic surgery for neuroendocrine tumors of the pancreas.
    Gharios J; Hain E; Dohan A; Prat F; Terris B; Bertherat J; Coriat R; Dousset B; Gaujoux S
    Best Pract Res Clin Endocrinol Metab; 2019 Oct; 33(5):101294. PubMed ID: 31351817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Surgery of pancreatic neuroendocrine neoplasms: state of the art].
    Nießen A; Schimmack S; Billmann F; Hackert T
    Chirurgie (Heidelb); 2022 Aug; 93(8):745-750. PubMed ID: 35499762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pattern and clinical predictors of lymph node involvement in nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs).
    Partelli S; Gaujoux S; Boninsegna L; Cherif R; Crippa S; Couvelard A; Scarpa A; Ruszniewski P; Sauvanet A; Falconi M
    JAMA Surg; 2013 Oct; 148(10):932-9. PubMed ID: 23986355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic Neuroendocrine Tumors (panNETs): Analysis of Overall Survival of Nonsurgical Management Versus Surgical Resection.
    Finkelstein P; Sharma R; Picado O; Gadde R; Stuart H; Ripat C; Livingstone AS; Sleeman D; Merchant N; Yakoub D
    J Gastrointest Surg; 2017 May; 21(5):855-866. PubMed ID: 28255853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic neuroendocrine tumors: Preoperative factors that predict lymph node metastases to guide operative strategy.
    Postlewait LM; Ethun CG; Baptiste GG; Le N; McInnis MR; Cardona K; Russell MC; Sarmiento JM; Kooby DA; Staley CA; Maithel SK
    J Surg Oncol; 2016 Sep; 114(4):440-5. PubMed ID: 27334541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
    Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
    Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parenchyma-sparing resections for pancreatic neoplasms.
    Crippa S; Boninsegna L; Partelli S; Falconi M
    J Hepatobiliary Pancreat Sci; 2010 Nov; 17(6):782-7. PubMed ID: 19865792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Pre-operative Inflammatory Markers as Predictors of Lymph Node Positivity and Disease Recurrence in Well-Differentiated Pancreatic Neuroendocrine Tumours: Pancreas2000 Research and Educational Program (Course 9).
    Tanno L; Pea A; Nykänen T; Prasad P; Tuncer C; Marchegiani G; Robinson S
    Front Med (Lausanne); 2020; 7():346. PubMed ID: 32850881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parenchyma-Sparing Pancreatic Resections: With or Without a Pancreaticojejunostomy?
    Wroński M; Cebulski W; Krasnodębski IW; Słodkowski M
    Hepatogastroenterology; 2014 Jun; 61(132):1113-7. PubMed ID: 26158173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indications for resection and perioperative outcomes of surgery for pancreatic neuroendocrine neoplasms in Germany: an analysis of the prospective DGAV StuDoQ|Pancreas registry.
    Mintziras I; Keck T; Werner J; Fichtner-Feigl S; Wittel U; Senninger N; Vowinkel T; Köninger J; Anthuber M; Geißler B; Bartsch DK;
    Surg Today; 2019 Dec; 49(12):1013-1021. PubMed ID: 31240463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymph node sampling rates and predictors of nodal metastasis in pancreatic neuroendocrine tumor resections: the UCSF experience with 149 patients.
    Parekh JR; Wang SC; Bergsland EK; Venook AP; Warren RS; Kim GE; Nakakura EK
    Pancreas; 2012 Aug; 41(6):840-4. PubMed ID: 22781907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there a role for near-infrared technology in laparoscopic resection of pancreatic neuroendocrine tumors? Results of the COLPAN "colour-and-resect the pancreas" study.
    Paiella S; De Pastena M; Landoni L; Esposito A; Casetti L; Miotto M; Ramera M; Salvia R; Secchettin E; Bonamini D; Manzini G; D'Onofrio M; Marchegiani G; Bassi C
    Surg Endosc; 2017 Nov; 31(11):4478-4484. PubMed ID: 28374260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Surgical and Therapeutic Activities of Non-Functional Pancreatic Neuroendocrine Tumors at a High-Volume Institution.
    Zhang WH; Xu JF; Hu YH; Qin Y; Chen J; Yu XJ; Xu XW; Ji SR
    Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of central pancreatectomy and pancreatic enucleation as pancreatic resections--A comparison.
    Wolk S; Distler M; Kersting S; Weitz J; Saeger HD; Grützmann R
    Int J Surg; 2015 Oct; 22():118-24. PubMed ID: 26278665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current Management of Pancreatic Neuroendocrine Tumors: From Demolitive Surgery to Observation.
    Bartolini I; Bencini L; Risaliti M; Ringressi MN; Moraldi L; Taddei A
    Gastroenterol Res Pract; 2018; 2018():9647247. PubMed ID: 30140282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastroenteropancreatic neuroendocrine tumors: Role of surgery.
    Sauvanet A
    Ann Endocrinol (Paris); 2019 Jun; 80(3):175-181. PubMed ID: 31079831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventive medicine of von Hippel-Lindau disease-associated pancreatic neuroendocrine tumors.
    Krauss T; Ferrara AM; Links TP; Wellner U; Bancos I; Kvachenyuk A; Villar Gómez de Las Heras K; Yukina MY; Petrov R; Bullivant G; von Duecker L; Jadhav S; Ploeckinger U; Welin S; Schalin-Jäntti C; Gimm O; Pfeifer M; Ngeow J; Hasse-Lazar K; Sansó G; Qi X; Ugurlu MU; Diaz RE; Wohllk N; Peczkowska M; Aberle J; Lourenço DM; Pereira MAA; Fragoso MCBV; Hoff AO; Almeida MQ; Violante AHD; Quidute ARP; Zhang Z; Recasens M; Díaz LR; Kunavisarut T; Wannachalee T; Sirinvaravong S; Jonasch E; Grozinsky-Glasberg S; Fraenkel M; Beltsevich D; Egorov VI; Bausch D; Schott M; Tiling N; Pennelli G; Zschiedrich S; Därr R; Ruf J; Denecke T; Link KH; Zovato S; von Dobschuetz E; Yaremchuk S; Amthauer H; Makay Ö; Patocs A; Walz MK; Huber TB; Seufert J; Hellman P; Kim RH; Kuchinskaya E; Schiavi F; Malinoc A; Reisch N; Jarzab B; Barontini M; Januszewicz A; Shah N; Young WF; Opocher G; Eng C; Neumann HPH; Bausch B
    Endocr Relat Cancer; 2018 Sep; 25(9):783-793. PubMed ID: 29748190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.